Mahendran Thamby Rajah, Cynthia Binsin, Thevendran Ramesh, Maheswaran Solayappan
School of Biological Sciences, Universiti Sains Malaysia, 11800, Minden, Penang, Malaysia.
Centre of Excellence for Nanobiotechnology & Nanomedicine (CoExNano), Faculty of Applied Sciences, AIMST University, 08100, Bedong, Kedah, Malaysia.
Mol Biotechnol. 2025 Jul;67(7):2598-2606. doi: 10.1007/s12033-024-01240-4. Epub 2024 Aug 1.
The sudden global crisis of COVID-19, driven by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), demands swift containment measures due to its rapid spread and numerous problematic mutations, which complicate the establishment of herd immunity. With escalating fatalities across various nations no foreseeable end in sight, there is a pressing need to create swiftly deployable, rapid, cost-effective detection, and treatment methods. While various steps are taken to mitigate the transmission and severity of the disease, vaccination is proven throughout mankind history as the best method to acquire immunity and circumvent the spread of infectious diseases. Nonetheless, relying solely on vaccination might not be adequate to match the relentless viral mutations observed in emerging variants of SARS-CoV-2, including alterations to their RBD domain, acquisition of escape mutations, and potential resistance to antibody binding. Beyond the immune system activation achieved through vaccination, it is crucial to develop new medications or treatment methods to either impede the infection or enhance existing treatment modalities. This review emphasizes innovative treatment strategies that aim to directly disrupt the virus's ability to replicate and spread, which could play a role in ending the SARS-CoV-2 pandemic.
由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发的全球突发新冠危机,因其迅速传播和众多有问题的突变,需要迅速采取遏制措施,这些突变使群体免疫的建立变得复杂。随着各国死亡人数不断攀升且看不到可预见的终点,迫切需要迅速开发可快速部署、快速且具有成本效益的检测和治疗方法。虽然已采取各种措施来减轻疾病的传播和严重程度,但在人类历史上,疫苗接种被证明是获得免疫力和避免传染病传播的最佳方法。然而,仅依靠疫苗接种可能不足以应对在SARS-CoV-2新出现变体中观察到的持续不断的病毒突变,包括其受体结合域(RBD)的改变、逃逸突变的获得以及对抗体结合的潜在抗性。除了通过疫苗接种激活免疫系统外,开发新的药物或治疗方法以阻止感染或增强现有治疗方式至关重要。本综述强调旨在直接破坏病毒复制和传播能力的创新治疗策略,这可能在终结SARS-CoV-2大流行中发挥作用。